Bank Pictet & Cie (Europe)’s SOPHiA GENETICS SOPH Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47M	Hold	255,200	–	–	0.03%	121
2026 Q1	$1.26M	Hold	255,200	–	–	0.03%	130
2025 Q4	$1.19M	Hold	255,200	–	–	0.02%	128
2025 Q3	$1.21M	Hold	255,200	–	–	0.02%	122
2025 Q2	$791K	Hold	255,200	–	–	0.02%	139
2025 Q1	$847K	Buy	255,200 +32,200	+14%	+$113K	0.02%	119
2024 Q4	$696K	Hold	223,000	–	–	0.02%	123
2024 Q3	$811K	Hold	223,000	–	–	0.02%	107
2024 Q2	$1.02M	Hold	223,000	–	–	0.02%	103
2024 Q1	$1.1M	Sell	223,000 -4,600	-2%	-$22.2K	0.03%	106
2023 Q4	$1.07M	Hold	227,600	–	–	0.03%	140
2023 Q3	$580K	Hold	227,600	–	–	0.02%	164
2023 Q2	$1.02M	Hold	227,600	–	–	0.03%	140
2023 Q1	$1.13M	Hold	227,600	–	–	0.05%	103
2022 Q4	$469K	Hold	227,600	–	–	0.02%	123
2022 Q3	$599K	Hold	227,600	–	–	0.03%	116
2022 Q2	$824K	Hold	227,600	–	–	0.04%	105
2022 Q1	$1.76M	Buy	+227,600	New	+$2.56M	0.07%	90

Other funds holding SOPH

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

AWA

Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return

HCM

Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s SOPH Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 255,200 shares worth $1.47M. The position accounts for 0.03% of the portfolio, ranked #121.

Bank Pictet & Cie (Europe) first reported a position in SOPH in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.76M in Q1 2022. 26 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

Bank Pictet & Cie (Europe) held 255,200 shares of SOPHiA GENETICS worth $1.47M as of Q2 2026.
Bank Pictet & Cie (Europe) left its SOPHiA GENETICS share count unchanged in Q2 2026.
SOPHiA GENETICS made up 0.03% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #121 holding.
Bank Pictet & Cie (Europe) first reported a position in SOPHiA GENETICS in Q1 2022 and has held it in 18 quarters since.
Bank Pictet & Cie (Europe)'s SOPHiA GENETICS position peaked at $1.76M in Q1 2022.
26 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.